Neurotrophic Effects of Induced Neural Stem Cell Grafts Following Traumatic Brain Injury

Gao Mou,Xu Ruxiang,Wang Wenjia,Dong Qin,Ding Boyun,Yao Hui,Yang Zhijun
DOI: https://doi.org/10.3877/cma.j.issn.2095-123x.2019.02.009
2019-01-01
Abstract:Objective To study the neurotrophic effects of grafted induced neural stem cells (iNSCs) following traumatic brain injury (TBI). Methods Healthy adult male C57BL/6 mouse TBI models were established using a standardized weight-drop device. Mice having an neurological severity scores (NSS) of 4-8 were randomly assigned to two groups: the iNSC group (n=12) and the phosphate buffered solution (PBS) group (n=9). Sham-operated mice underwent the same procedures, but not head trauma (n=9). At 12 h post-injury, iNSCs (1×106 cells) or PBS were separately injected into the brains of TBI mice via stereotactic method. On day 7 after TBI, animals were sacrificed for molecular-biological and morphological analysis. RT-qPCR and ELISA were utilized to determine the levels of BDNF and GDNF expression. To explore the neurotrophic effects of iNSCs, we utilized immunofluorescent staining to detect the expression of BDNF and GDNF in iNSC grafts. Results RT-qPCR assay revealed that the expression levels of Bdnf and Gdnf were significantly lower in the TBI group than in the sham group (P<0.05). Furthermore, the levels of Bdnf and Gdnf expression were significantly higher in the iNSC group than in the PBS group (P<0.05). ELISA indicated that the expression levels of BDNF and GDNF were significantly lower in the TBI group than in the sham group (P<0.05). Furthermore, the levels of BDNF and GDNF expression were significantly higher in the iNSC group than in the PBS group (P<0.05). Immunofluorescent staining showed that GFP-labelling iNSCs migrated to the damaged area and expressed BDNF and GDNF. Conclusion Stereotactic transplantation of iNSCs can express BDNF and GDNF to play neurotrophic effects following TBI. Key words: Induced neural stem cell; Traumatic brain injury; Brain-derived neurotrophic factor; Glial cell-line derived neurotrophic factor; Transplantation
What problem does this paper attempt to address?